BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33516249)

  • 1. High clinical heterogeneity in a Chinese pedigree of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S).
    Xie N; Sun Q; Yang J; Zhou Y; Xu H; Zhou L; Zhou Y
    Orphanet J Rare Dis; 2021 Jan; 16(1):56. PubMed ID: 33516249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial magnetic resonance imaging changes of pseudotumor lesions in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a case report.
    Yan Y; Jiang S; Wang R; Wang X; Li P; Wu B
    BMC Neurol; 2021 Jun; 21(1):219. PubMed ID: 34107918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Mortality and Vascular Phenotype in a Knock-In Mouse Model of Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.
    Mulder IA; Rubio-Beltran E; Ibrahimi K; Dzyubachyk O; Khmelinskii A; Hoehn M; Terwindt GM; Wermer MJH; MaassenVanDenBrink A; van den Maagdenberg AMJM
    Stroke; 2020 Jan; 51(1):300-307. PubMed ID: 31805844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel de novo TREX1 mutation in a patient with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations mimicking demyelinating disease.
    Macaron G; Khoury J; Hajj-Ali RA; Prayson RA; Srivastava S; Ehlers JP; Mamsa H; Liszewski MK; Jen JC; Bermel RA; Ontaneda D
    Mult Scler Relat Disord; 2021 Jul; 52():103015. PubMed ID: 34044261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S): An update on basic science and clinical perspectives.
    Wilms AE; de Boer I; Terwindt GM
    Cereb Circ Cogn Behav; 2022; 3():100046. PubMed ID: 36324396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Endothelial Markers in Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.
    Pelzer N; Bijkerk R; Reinders MEJ; van Zonneveld AJ; Ferrari MD; van den Maagdenberg AMJM; Eikenboom J; Terwindt GM
    Stroke; 2017 Dec; 48(12):3301-3307. PubMed ID: 29114091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.
    Hoogeveen ES; Pelzer N; Ghariq E; van Osch MJ; Dahan A; Terwindt GM; Kruit MC
    J Cereb Blood Flow Metab; 2021 Apr; 41(4):831-840. PubMed ID: 33736510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease.
    Pelzer N; Hoogeveen ES; Haan J; Bunnik R; Poot CC; van Zwet EW; Inderson A; Fogteloo AJ; Reinders MEJ; Middelkoop HAM; Kruit MC; van den Maagdenberg AMJM; Ferrari MD; Terwindt GM
    J Intern Med; 2019 Mar; 285(3):317-332. PubMed ID: 30411414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal vasculopathy with cerebral leukoencephalopathy carrying TREX1 mutation diagnosed by the intracranial calcification: a case report].
    Komaki R; Ueda T; Tsuji Y; Miyawaki T; Kusuhara S; Hara S; Toda T
    Rinsho Shinkeigaku; 2018 Feb; 58(2):111-117. PubMed ID: 29386495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of the von Willebrand Factor - ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S).
    Braune M; Metelmann M; de Fallois J; Pfrepper C; Barrantes-Freer A; Hiller GGR; Unger S; Seelow E; Halbritter J; Pelz JO
    Neurol Res Pract; 2024 Jun; 6(1):32. PubMed ID: 38898536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: Critical Role of Retina Specialists.
    Houghton OM; Carter J; Dhamija R
    J Vitreoretin Dis; 2023; 7(2):171-177. PubMed ID: 37006667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited C-terminal TREX1 variants disrupt homology-directed repair to cause senescence and DNA damage phenotypes in Drosophila, mice, and humans.
    Chauvin SD; Ando S; Holley JA; Sugie A; Zhao FR; Poddar S; Kato R; Miner CA; Nitta Y; Krishnamurthy SR; Saito R; Ning Y; Hatano Y; Kitahara S; Koide S; Stinson WA; Fu J; Surve N; Kumble L; Qian W; Polishchuk O; Andhey PS; Chiang C; Liu G; Colombeau L; Rodriguez R; Manel N; Kakita A; Artyomov MN; Schultz DC; Coates PT; Roberson EDO; Belkaid Y; Greenberg RA; Cherry S; Gack MU; Hardy T; Onodera O; Kato T; Miner JJ
    Nat Commun; 2024 Jun; 15(1):4696. PubMed ID: 38824133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RVCL-S and CADASIL display distinct impaired vascular function.
    de Boer I; Stam AH; Buntinx L; Zielman R; van der Steen I; van den Maagdenberg AMJM; de Koning EJP; Ferrari MD; de Hoon JN; Terwindt GM
    Neurology; 2018 Sep; 91(10):e956-e963. PubMed ID: 30076273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy.
    DiFrancesco JC; Novara F; Zuffardi O; Forlino A; Gioia R; Cossu F; Bolognesi M; Andreoni S; Saracchi E; Frigeni B; Stellato T; Tolnay M; Winkler DT; Remida P; Isimbaldi G; Ferrarese C
    Neurol Sci; 2015 Feb; 36(2):323-30. PubMed ID: 25213617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vasculopathy with cerebral leukoencephalopathy (RVCL): A rare mimic of tumefactive MS.
    Raynowska J; Miskin DP; Pramanik B; Asiry S; Anderson T; Boockvar J; Najjar S; Harel A
    Neurology; 2018 Oct; 91(15):e1423-e1428. PubMed ID: 30194247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREX1 is expressed by microglia in normal human brain and increases in regions affected by ischemia.
    Kothari PH; Kolar GR; Jen JC; Hajj-Ali R; Bertram P; Schmidt RE; Atkinson JP
    Brain Pathol; 2018 Nov; 28(6):806-821. PubMed ID: 30062819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal Vasculopathy With Cerebral Leukodystrophy: Clinicopathologic Features of an Autopsied Patient With a Heterozygous TREX 1 Mutation.
    Saito R; Nozaki H; Kato T; Toyoshima Y; Tanaka H; Tsubata Y; Morioka T; Horikawa Y; Oyanagi K; Morita T; Onodera O; Kakita A
    J Neuropathol Exp Neurol; 2019 Feb; 78(2):181-186. PubMed ID: 30561700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic Variability in a Mexican Mestizo Family with Retinal Vasculopathy with Cerebral Leukodystrophy and TREX1 Mutation p.V235Gfs*6.
    Monroy-Jaramillo N; Cerón A; León E; Rivas V; Ochoa-Morales A; Arteaga-Alcaraz MG; Nocedal-Rustrian FC; Gallegos C; Alonso-Vilatela ME; Corona T; Flores J
    Rev Invest Clin; 2018; 70(2):68-75. PubMed ID: 29718010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy.
    Ford AL; Chin VW; Fellah S; Binkley MM; Bodin AM; Balasetti V; Taiwo Y; Kang P; Lin D; Jen JC; Grand MG; Bogacki M; Liszewski MK; Hourcade D; Chen Y; Hassenstab J; Lee JM; An H; Miner JJ; Atkinson JP
    Neurology; 2020 Oct; 95(14):e1918-e1931. PubMed ID: 32887784
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.